← Back to Vaccine Database

AdCLD-CoV19 (adenovirus vector)

Viral vector (Non-replicating) vaccine · VDDBV0058

Target & Classification

SARS-CoV-2SARS-CoV-2
Viral vector (Non-replicating) vaccine
COVID-19
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT05047692 Phase 1COVID-19
NCT04666012 Phase 2COVID-19